453
Views
6
CrossRef citations to date
0
Altmetric
Review

Current trends in the use of human serum albumin for drug delivery in cancer

, , ORCID Icon & ORCID Icon
Pages 1449-1470 | Received 15 Jun 2022, Accepted 05 Oct 2022, Published online: 17 Oct 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jianmin Li, Wenyi Zhang, Shuang Liu, Fan Yang, Yupeng Zhou, Lin Cao, Yiming Li, Yunfei Guo, Xiang Qi, Guoping Xu, Jing Peng & Yang Zhao. (2023) Preclinical Evaluation of a Protein-Based Nanoscale Contrast Agent for MR Angiography at an Ultralow Dose. International Journal of Nanomedicine 18, pages 4431-4444.
Read now
Yao Chen, Shuya Liu, Yin Liao, Hanshan Yang, Zhuo Chen, Yuru Hu, Shaozhi Fu & Jingbo Wu. (2023) Albumin-Modified Gold Nanoparticles as Novel Radiosensitizers for Enhancing Lung Cancer Radiotherapy. International Journal of Nanomedicine 18, pages 1949-1964.
Read now

Articles from other publishers (4)

Paolo Coghi, Jinxin Li, Narayan S. Hosmane & Yinghuai Zhu. (2023) Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment. Medicinal Research Reviews 43:5, pages 1809-1830.
Crossref
Zhenlei Zhang, Juzheng Zhang, Tongfu Yang, Shanhe Li, Gang Xu, Hong Liang & Feng Yang. (2023) Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin. Journal of Medicinal Chemistry 66:8, pages 5669-5684.
Crossref
Elmira A. Vasilieva, Darya A. Kuznetsova, Farida G. Valeeva, Denis M. Kuznetsov & Lucia Ya. Zakharova. (2023) Role of Polyanions and Surfactant Head Group in the Formation of Polymer–Colloid Nanocontainers. Nanomaterials 13:6, pages 1072.
Crossref
Tarun Patel, Asif Mohd Itoo, Milan Paul, Likhitha Purna Kondapaneni, Balaram Ghosh & Swati Biswas. (2023) Block HPMA-based pH-sensitive gemcitabine pro-drug nanoaggregates for cancer treatment. European Polymer Journal 186, pages 111843.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.